ArticlePloS one2020
Validation of the Mobile Application Rating Scale (MARS).
Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers, 21 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
146 citing papers in PubMed, 21 syntheses or guidelines pooled it.
- Evaluation of fatty liver disease self-care applications: a systematic review and evaluation of apps using the mobile application rating scale (MARS).BMC gastroenterology · 2026Pooled it
- Persuasive Systems Design Features of Smartphone Apps for Psychosis: Systematic Review.JMIR human factors · 2026Pooled it
- Clinical Usability of Exercise Prescription Apps for Professional Use: Systematic Review and Multidimensional Evaluation.JMIR mHealth and uHealth · 2026Pooled it
- The Landscape of Mobile Apps for Healthy Eating: Case Study for a Systematic Review and Quality Assessment.JMIR mHealth and uHealth · 2026Pooled it
- Evaluating Characteristics and Quality of Mental Health Apps Available in App Stores for Indian Users: Systematic App Search and Review.JMIR mHealth and uHealth · 2025Pooled it
- Evaluation of temporomandibular disorder self-management apps in Australia: a systematic review to inform clinical use.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2025Pooled it
- Self-Management Support Apps for Spinal Cord Injury: Results of a Systematic Search in App Stores and Mobile App Rating Scale Evaluation.JMIR mHealth and uHealth · 2024Pooled it
- Smartphone Apps for Pulmonary Hypertension: Systematic Search and Content Evaluation.JMIR mHealth and uHealth · 2024Pooled it
- A Systematic Review of Cervical Cancer Mobile Applications and a Future Directions for Developers.Asian Pacific journal of cancer prevention : APJCP · 2024Pooled it
- Heterogeneity of Treatment Effects in Internet- and Mobile-Based Interventions for Depression: A Systematic Review and Meta-Analysis.JAMA network open · 2024Pooled it
- Quality and Accessibility of Home Assessment mHealth Apps for Community Living: Systematic Review.JMIR mHealth and uHealth · 2024Pooled it
- Evaluation of Patient-Facing Mobile Apps to Support Physiotherapy Care: Systematic Review.JMIR mHealth and uHealth · 2024Pooled it
- Functionality and Quality of Asthma mHealth Apps and Their Consistency With International Guidelines: Structured Search and Evaluation.JMIR mHealth and uHealth · 2024Pooled it
- A systematic review of features and content quality of Arabic mental mHealth apps.Frontiers in digital health · 2024Pooled it
- Mobile health apps for cardiovascular risk assessment: a systematic review.Frontiers in cardiovascular medicine · 2024Pooled it
- Scope, Characteristics, Behavior Change Techniques, and Quality of Conversational Agents for Mental Health and Well-Being: Systematic Assessment of Apps.Journal of medical Internet research · 2023Pooled it
- Pooled it
- Mobile health in the specific management of first-episode psychosis: a systematic literature review.Frontiers in psychiatry · 2023Pooled it
- Mobile Apps for the Management of Gastrointestinal Diseases: Systematic Search and Evaluation Within App Stores.Journal of medical Internet research · 2022Pooled it
- Smartphone Apps for Patients With Hematologic Malignancies: Systematic Review and Evaluation of Content.JMIR mHealth and uHealth · 2022Pooled it
86 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMobile health apps (MHA) have the potential to improve health care. The commercial MHA market is rapidly growing, but the content and quality of available MHA are unknown. Instruments for the assessment of the quality and content of MHA are highly needed. The Mobile Application Rating Scale (MARS) is one of the most widely used tools to evaluate the quality of MHA. Only few validation studies investigated its metric quality. No study has evaluated the construct validity and concurrent validity.
objectiveThis study evaluates the construct validity, concurrent validity, reliability, and objectivity, of the MARS.
methodsData was pooled from 15 international app quality reviews to evaluate the metric properties of the MARS. The MARS measures app quality across four dimensions: engagement, functionality, aesthetics and information quality. Construct validity was evaluated by assessing related competing confirmatory models by confirmatory factor analysis (CFA). Non-centrality (RMSEA), incremental (CFI, TLI) and residual (SRMR) fit indices were used to evaluate the goodness of fit. As a measure of concurrent validity, the correlations to another quality assessment tool (ENLIGHT) were investigated. Reliability was determined using Omega. Objectivity was assessed by intra-class correlation.
resultsIn total, MARS ratings from 1,299 MHA covering 15 different health domains were included. Confirmatory factor analysis confirmed a bifactor model with a general factor and a factor for each dimension (RMSEA = 0.074, TLI = 0.922, CFI = 0.940, SRMR = 0.059). Reliability was good to excellent (Omega 0.79 to 0.93). Objectivity was high (ICC = 0.82). MARS correlated with ENLIGHT (ps<.05).
conclusionThe metric evaluation of the MARS demonstrated its suitability for the quality assessment. As such, the MARS could be used to make the quality of MHA transparent to health care stakeholders and patients. Future studies could extend the present findings by investigating the re-test reliability and predictive validity of the MARS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.